ViroPharma beats Street

ViroPharma Inc. (NASDAQ:VPHM) reported 2Q10 diluted GAAP EPS of $0.34, beating by $0.02 the Street's estimate of $0.32 and up from $0.20 in 2Q09. Revenues for the quarter were $109 million, up 33% fro...